Mumenthaler Christian Stephane 4

What Happened

• Christian Stephane Mumenthaler, a director of MetLife, was credited with 17 shares of MetLife common stock on March 10, 2026. The shares were recorded at $70.60 each, for a total imputed value of $1,200. This transaction is an award/acquisition (A) representing an imputed reinvestment of dividends into deferred shares rather than an open‑market purchase.

Key Details

• Transaction date and price: 2026-03-10 — 17 shares @ $70.60 each.
• Transaction value: approximately $1,200.
• Shares owned after transaction: not specified in the filing.
• Footnote: The shares are an imputed reinvestment of dividends under the MetLife Deferred Compensation Plan for Non‑Management Directors (deferred shares represent stock that has become payable but the director has deferred receipt).
• Filing: Report filed 2026-03-12 for a 2026-03-10 transaction (filed two days after the transaction; appears timely).

Context

• This was a routine crediting of deferred shares tied to dividend reinvestment rather than a purchase or sale in the open market. Such entries are common for directors participating in deferred compensation plans and do not, by themselves, indicate a change in the director's view of the company.